SEC Tracker
Get the app

8-KTMDX

TransMedics reports Q3 2026 results

The third quarter of 2026 saw total revenue of $203.0 million, up 41% from $143.8 million in the same period in 2025.1

By SEC Tracker ·

TransMedics GroupCIK 1756262Form 8-KFiled Nov 5, 2026, 4:02 PM ET0001193125-26-449729Read the filing on SEC.gov →

Product revenue was $113.4 million, and service revenue was $89.6 million.2 Net income for the quarter was $17.1 million, or $0.46 per diluted share.3

TransMedics raised its full-year 2026 revenue guidance to between $764-$774 million, including $14 million from PAD Aviation.4 The company also received FDA approvals for ENHANCE Heart Part B and DENOVO Lung trials.5

Key facts

Company
TransMedics Group (TMDX)
CIK
1756262
Form
8-K
Items
2.02, 9.01
Filed
Nov 5, 2026, 4:02 PM ET
Accession
0001193125-26-449729

From the EDGAR filing index, not written by AI.

TransMedics Group results from its filings

Revenue, net income and cash as tagged in XBRL in the company's 10-Q and 10-K filings, up to this filing. Drawn in code; no figure here is written by AI.

TransMedics Group revenue and net income by quarterRevenueNet income$ millionsSource: XBRL in the company's 10-Q and 10-K filings, SEC EDGAR050100150200250Revenue · Q2 FY26: 189.9189.9Net income · Q2 FY26: 14.714.7Revenue · Q3 FY26: 203.0203.0Net income · Q3 FY26: 17.117.1Q2 FY26Q3 FY26
TransMedics Group cash at period end$ millionsSource: XBRL in the company's 10-Q and 10-K filings, SEC EDGAR0100200300400500493.0Q2 FY26Q3 FY26Cash · Q2 FY26: 472.7Cash · Q3 FY26: 493.0
The numbers
PeriodRevenueNet incomeCashFiling
Q2 FY26$189.9M$14.7M$472.7M10-Q
Q3 FY26$203.0M$17.1M$493.0M10-Q

How often TransMedics Group files

Filings per calendar quarter, counted in code from the company's EDGAR filing list. Each bar splits 8-K current reports from other forms; the last bar is the quarter of this filing, counted up to it.

TransMedics Group filings per quarter8-KOther formsSource: EDGAR filing list, counted in code05101520258-K · Q1 25: 3Other forms · Q1 25: 98-K · Q2 25: 2Other forms · Q2 25: 198-K · Q3 25: 1Other forms · Q3 25: 58-K · Q4 25: 2Other forms · Q4 25: 98-K · Q1 26: 4Other forms · Q1 26: 148-K · Q2 26: 2Other forms · Q2 26: 188-K · Q3 26: 2Other forms · Q3 26: 78-K · Q4 26: 1Other forms · Q4 26: 21221611182093Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
TransMedics Group filings per quarter
The numbers
QuarterFilings8-K
Q1 25123
Q2 25212
Q3 2561
Q4 25112
Q1 26184
Q2 26202
Q3 2692
Q4 2631

Timeline

The company's filings on EDGAR around this one, newest first. Ownership forms and routine prospectus filings are left out.

  1. Form 8-KThis filing
  2. Form 10-Q
  3. Form 8-K
  4. Form 10-Q
  5. Form 8-K
  6. Form SD

Get an email when TransMedics Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Written with AI from the TransMedics Group Form 8-K and checked against it sentence by sentence: each of the 5 numbered sentences opens the passage it comes from. AI can make mistakes. Check the filing. Not investment advice. Not affiliated with the U.S. SEC. Source filing on SEC.gov.

Data on this page was fetched . The filing on SEC.gov is the record.